Cowen Royalty appoints Strategic Advisory Board

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Sep 18 2009

Cowen Healthcare Royalty Partners ("Cowen Royalty") today announced that it has established a Strategic Advisory Board to extend the Firm's functional knowledge and geographic base within the healthcare industry. The Board will be comprised of industry veterans with complementary backgrounds and significant general management experience. Each member is expected to supplement Cowen Royalty's due diligence, opportunity assessment, business development and portfolio management capabilities.

The initial five board appointments include Dr. Frank Armstrong, Louis P. Berneman, Dr. Michael G. Carter, Timothy P. Lynch and Nicholas L. Teti, Jr.

Source:

http://www.cowenroyalty.com

Posted in:

Tags:

Comments (0)

Suggested Reading

FUJIFILM Healthcare Europe introduces EndoGel training model for endoscopic procedures
University of Liverpool invests £1M in state-of-the-art teaching facilities for healthcare students
Can generative AI truly transform healthcare into a more personalized experience?
Emerging trends in wearable breath sensors aim at personalized healthcare solutions
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness
Aster DM Healthcare reveals top foods to combat PCOS symptoms
Americans perceive mental health treatment as inferior to physical health care, survey reveals
Research collaboration could help promote health and reduce injuries in NBA G League players

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Ovum AI launches Australia’s first longitudinal dataset to revolutionize women’s healthcare